Author:
Kaneko Hiroto,Shimura Kazuho,Kuwahara Saeko,Ohshiro Muneo,Tsutsumi Yasuhiko,Iwai Toshiki,Horiike Shigeo,Yokota Shouhei,Ohkawara Yasuo,Taniwaki Masafumi
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Horiike S, Misawa S, Taniwaki M, Abe T: Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for the prognosis. Cancer. 1988, 62: 1129-1138. 10.1002/1097-0142(19880915)62:6<1129::AID-CNCR2820620616>3.0.CO;2-C.
2. Greenberg P, Cox C, Le Beau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J: International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997, 89: 2079-2088.
3. Le Beau MM, Espinosa R, Davis EM, Eisenbart JD, Larson RA, Green ED: Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood. 1996, 88: 1930-1935.
4. Johnson EJ, Scherer SW, Osborne L, Tsui LC, Oscier D, Mould S, Cotter FE: Molecular definition of a narrow interval at 7q22.1 associated with myelodysplasia. Blood. 1996, 87: 3579-3586.
5. Lewis S, Abrahamson G, Boultwood J, Fidler C, Potter A, Wainscoat JS: Molecular characterization of the 7q deletion in myeloid disorders. Br J Haematol. 1996, 93: 75-80. 10.1046/j.1365-2141.1996.4841025.x.